<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="9057" OLDID="14578" TOPICS="NO">
<DATE>24-MAR-1987 17:08:39.15</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f2616 reute
r f BC-INTERLEUKIN-2-&lt;ILTO&gt;   03-24 0057</UNKNOWN>
<TEXT> 
<TITLE>INTERLEUKIN-2 &lt;ILTO&gt; DETAILS WARRANT CONVERSION</TITLE>
<DATELINE>    WASHINGTON, March 24 - </DATELINE><BODY>Interleukin-2 Inc said the
registration of warrants became effective March 20 and that 3.5
mln warrants will be convertible into 1.75 mln shares of the
company's common stock, giving the company a maximum of 2.4 mln
dlrs.
    The warrants must be exercised by June 22.
 Reuter
 </BODY></TEXT>
</REUTERS>